| scholarly article | Q13442814 |
| P2093 | author name string | Susanne Keipert | |
| Marlou Klein Hazebroek | |||
| P2860 | cites work | Identification of a novel FGF, FGF-21, preferentially expressed in the liver | Q22254289 |
| Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 | Q24318639 | ||
| FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response | Q24653481 | ||
| BetaKlotho is required for metabolic activity of fibroblast growth factor 21 | Q24681531 | ||
| The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria | Q28115102 | ||
| FGF21 requires βklotho to act in vivo | Q28485347 | ||
| Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese | Q28510931 | ||
| FGF21 is an endocrine signal of protein restriction | Q28572009 | ||
| Brown adipose tissue: function and physiological significance | Q29547448 | ||
| Serum FGF21 levels are associated with brown adipose tissue activity in humans. | Q30374773 | ||
| p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene | Q33199648 | ||
| Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. | Q33762194 | ||
| FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. | Q34315567 | ||
| Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans | Q34403054 | ||
| Thermogenic activation induces FGF21 expression and release in brown adipose tissue. | Q34787051 | ||
| Fibroblast growth factor 21 corrects obesity in mice | Q34805555 | ||
| FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis | Q35755169 | ||
| Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice | Q35763646 | ||
| High-fat diet and FGF21 cooperatively promote aerobic thermogenesis in mtDNA mutator mice | Q35865700 | ||
| A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat. | Q36307444 | ||
| Mild cold exposure modulates fibroblast growth factor 21 (FGF21) diurnal rhythm in humans: relationship between FGF21 levels, lipolysis, and cold-induced thermogenesis. | Q36508902 | ||
| FGF21 regulates metabolism and circadian behavior by acting on the nervous system | Q37161082 | ||
| A liver stress-endocrine nexus promotes metabolic integrity during dietary protein dilution | Q37217436 | ||
| Interplay between FGF21 and insulin action in the liver regulates metabolism | Q37524205 | ||
| Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease | Q37781747 | ||
| Understanding the Physiology of FGF21. | Q38665376 | ||
| FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms | Q38852382 | ||
| Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine | Q39042458 | ||
| Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. | Q39581682 | ||
| Thermogenic mechanisms in brown fat | Q40140016 | ||
| Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1. | Q40958865 | ||
| Low protein-induced increases in FGF21 drive UCP1-dependent metabolic but not thermoregulatory endpoints | Q41421048 | ||
| iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy | Q41440576 | ||
| Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of FGF21 secretion | Q41810632 | ||
| Mild cold induced thermogenesis: are BAT and skeletal muscle synergistic partners? | Q41948731 | ||
| FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho | Q42819634 | ||
| Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 | ||
| The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes | Q45834496 | ||
| Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys | Q46844955 | ||
| A low-protein diet induces body weight loss and browning of subcutaneous white adipose tissue through enhanced expression of hepatic fibroblast growth factor 21 (FGF21). | Q47244001 | ||
| The FGF21-CCL11 Axis Mediates Beiging of White Adipose Tissues by Coupling Sympathetic Nervous System to Type 2 Immunity. | Q47300790 | ||
| A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects | Q47319669 | ||
| Long-Term Cold Adaptation Does Not Require FGF21 or UCP1. | Q47813776 | ||
| FGF21 Is an Exocrine Pancreas Secretagogue. | Q51189900 | ||
| Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. | Q51421300 | ||
| Increased FGF21 in brown adipose tissue of tyrosine hydroxylase heterozygous mice: implications for cold adaptation | Q57797975 | ||
| Liver Derived FGF21 Maintains Core Body Temperature During Acute Cold Exposure | Q61444357 | ||
| Interaction between the amount of dietary protein and the environmental temperature on the expression of browning markers in adipose tissue of rats. | Q64946008 | ||
| UCP1 is essential for adaptive adrenergic nonshivering thermogenesis | Q83092333 | ||
| Induction of lipogenesis in white fat during cold exposure in mice: link to lean phenotype | Q88243697 | ||
| The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol | Q88363823 | ||
| Reduced adiposity by compensatory WAT browning upon iBAT removal in mice | Q88727338 | ||
| Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice | Q89474341 | ||
| A Genetic Model to Study the Contribution of Brown and Brite Adipocytes to Metabolism | Q90239463 | ||
| Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study | Q90300458 | ||
| Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial | Q90566894 | ||
| Circulating fibroblast growth factor 21 is reduced, whereas its production is increased in a fat depot-specific manner in cold-acclimated rats | Q90610388 | ||
| Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis | Q92403525 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 389 | |
| P577 | publication date | 2020-07-02 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Adapting to the Cold: A Role for Endogenous Fibroblast Growth Factor 21 in Thermoregulation? | |
| P478 | volume | 11 |
Search more.